亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Hybridoma 3C9 producing a monoclonal antibody (MAb) against Clostridium perfringens enterotoxin (CPE) and a recombinant E. coli strain producing CPE

詳細技術說明
None
*Abstract
Hybridoma 3C9 produces a mAb with very high affinity against Clostridium perfringens enterotoxin (CPE). It recognizes a linear epitope present in the C-terminal half of CPE. Consequently, the mAb can block CPE binding to cells and can neutralize CPE toxicity. It works on Western blots and ELISAs for CPE detection. Antigen: C. perfringens enterotoxinClone Name: 3C9Isotype: IgG1Immunogen:C- terminal of C. perfringens enterotoxinApplications: Western blot, ELISAsSpecies reactivity: Clostridium perfringensGene/Protein information:Manuscript reference: Wnek et al., Infection and Immunity, 1985, 50:442-448.The recombinant E. coli strain produces CPE with a His6 tag, which assists purification using metal affinity resins. This CPE is active and reacts with CPE antibodies, including the MAb produced by hybridoma 3C9 (Czeczulin et al., Infection and Immunity 1993, 61:3429-3439.).Available for non-exclusive license
*Principal Investigation

Name: John Czeczulin

Department:


Name: Philip Hanna

Department:


Name: Bruce McClane, Professor

Department: Med-Microbiology and Molecular Genetics


Name: Robert Strouse

Department:


Name: Andrew Wnek

Department:

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備